Since the introduction of biological therapies almost 2 decades ago, specifically, the anti-TNFα agents, major alterations of the natural history of rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) have been observed (1, 2). Here, TNF is linked to rheumatoid arthritis.